title: Commentary on Burns et al. (2015): retention in buprenorphine treatment.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Addiction Psychiatry Residency Program, University of Washington, Center of Excellence in Substance Abuse Treatment and Education (CESATE), VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA, 98108, USA. asaxon@uw.edu.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Saxon
mesh_terms: D002047:Buprenorphine / Q000627:therapeutic use*; D002056:Burns; D006801:Humans; D008691:Methadone / Q000627:therapeutic use; D058850:Opiate Substitution Treatment; D009293:Opioid-Related Disorders / Q000188:drug therapy
chemical_list: D002047:Buprenorphine; D008691:Methadone
keywords: Buprenorphine; medication assisted treatment; methadone; opioid use disorder; pharmacogenetics; treatment retention